NIDA Funds Research on Cocaine Addiction Drug
The National Institute on Drug Abuse (NIDA) has agreed to fund a midstage clinical trial of a cocaine-addiction drug called vigabatrin, produced by Catalyst Pharmaceutical Partners, Inc. The Associated Press reported April 13 that NIDA will fund a second series …







